DS
AGTC

David Shaw’s Applied Genetic Technologies Corporation AGTC Stock Holding History

David Shaw’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-54,702
Closed -$228K – 4236
2019
Q3 		$228K Sell
54,702
-3,200
-6% -$11.6K ﹤0.01% 3581
2019
Q2 		$219K Buy
57,902
+10,329
+22% +$42.3K ﹤0.01% 3438
2019
Q1 		$199K Buy
47,573
+21,040
+79% +$73.5K ﹤0.01% 3407
2018
Q4 		$66K Sell
26,533
-28,087
-51% -$165K ﹤0.01% 3670
2018
Q3 		$399K Buy
54,620
+22,560
+70% +$98.8K ﹤0.01% 3228
2018
Q2 		$119K Buy
32,060
+17,758
+124% +$82.2K ﹤0.01% 3600
2018
Q1 		$55K Sell
14,302
-1,688
-11% -$7.09K ﹤0.01% 3420
2017
Q4 		$58K Buy
+15,990
New +$60.4K ﹤0.01% 3528
2017
Q1 		– Sell
-11,085
Closed -$104K – 3681
2016
Q4 		$104K Sell
11,085
-1,012
-8% -$9.12K ﹤0.01% 3343
2016
Q3 		$118K Sell
12,097
-16,447
-58% -$222K ﹤0.01% 3273
2016
Q2 		$403K Sell
28,544
-39,200
-58% -$612K ﹤0.01% 2885
2016
Q1 		$947K Buy
67,744
+44,561
+192% +$654K ﹤0.01% 2392
2015
Q4 		$473K Buy
+23,183
New +$358K ﹤0.01% 3121

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

David Shaw's AGTC Position: Q4 2019 in Review

David Shaw sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2019, closing a stake of 54,702 shares — an estimated $228K sold.

David Shaw first reported a position in AGTC in Q4 2015 and held it in 13 quarters. The position peaked at $947K in Q1 2016. 52 funds tracked by Wall St. Rank hold AGTC as of Q4 2019.

  • David Shaw reported no remaining Applied Genetic Technologies Corporation position as of Q4 2019 after selling out during the quarter.
  • David Shaw sold 54,702 Applied Genetic Technologies Corporation shares in Q4 2019, an estimated $228K.
  • David Shaw first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 13 quarters.
  • David Shaw's Applied Genetic Technologies Corporation position peaked at $947K in Q1 2016.
  • 52 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.